Akebia Therapeutics: Q2 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Friday reported a second-quarter loss of $11.2 million, after reporting a profit in the same period a year earlier.
The Cambridge, Massachusetts-based company said it had a loss of 6 cents per share.
The kidney disease treatment developer posted revenue of $56.4 million in the period.
The company's shares closed at $1.25. A year ago, they were trading at 39 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
